Cleerly
Decision/Risk AnalysisWebsite
Developer of a healthcare platform designed to create a new standard of care for coronary artery disease. The company's platform has a non-invasive approach that supports the understanding of plaques ...
Valuation
$0
Share Price
N/A
Total Raised
$410.3M
Last Round
Later Stage VC (Series C)
Jul 2022
Latest Funding Round
Later Stage VC (Series C)
Jul 25, 2022
$230M
raised
Investors
+23 other investors